Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene

被引:12
作者
Operschall, E [1 ]
Pavlovic, J [1 ]
Nawrath, M [1 ]
Mölling, K [1 ]
机构
[1] Univ Zurich, Inst Med Virol, CH-8028 Zurich, Switzerland
关键词
DNA vaccine; influenza A virus; granulocyte-macrophage colony-stimulating factor; interleukin-12;
D O I
10.1159/000054000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Influenza A virus with its two major antigenic surface proteins hemagglutinin (HA) and neuraminidase (NA) is a widely used model to study DNA immunizations in mice and other animals. Natural protection against influenza A virus infection is mediated by antibodies, wh ich mostly a re not protective against antigen ic shift or drift variants of the original virus. Therefore, it would be a major task to induce a protective cellular immune response to more conserved proteins or epitopes, injection of plasmid encoding a viral antigen is known to induce cellular as well as humoral immunity. In this study we investigate the mechanism of protection after intramuscular vaccination of C57Bl/16 mice with a DNA vaccine encoding HA of influenza A/PR/8/34. After a single injection, only a small percentage of mice survive the lethal challenge with homologous virus. The amount of protection can be doubled by applying a booster injection. Furthermore, by coinjection of plasmids encoding cytokines GM-CSF and IL-12, respectively, nearly all of the mice are protected. Mice with specific defects in the cellular immune response [perforin knockout (P-/-) mice] and in the humoral immune response [IgD/IgM knockout (mu MT) mice], respectively, have been immunized with HA DNA with or without cytokine DNA. Protection could only be induced in P-/- mice, whereas mu MT mice succumbed to the infection. Moreover, when mu MT mice were infected with only 0.75 x 50% lethal dose they died all the same, whereby mice that had been depleted of CD8+ T cells before infection showed an even greater progression of illness. Altogether these results demonstrate that antibodies mediate protection after immunization with plasmid coding for HA of influenza A virus, and that booster immunizations and coinjection of plasmids encoding GM-CSF or IL-12 can improve this protection. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 52 条
[1]  
ADA GL, 1986, CURR TOP MICROBIOL, V128, P1
[2]   Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans [J].
Cauthen, AN ;
Swayne, DE ;
Schultz-Cherry, S ;
Perdue, ML ;
Suarez, DL .
JOURNAL OF VIROLOGY, 2000, 74 (14) :6592-6599
[3]   Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza [J].
Chen, Z ;
Sahashi, Y ;
Matsuo, K ;
Asanuma, H ;
Takahashi, H ;
Iwasaki, T ;
Suzuki, Y ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1998, 16 (16) :1544-1549
[4]   Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein [J].
Chen, Z ;
Yoshikawa, T ;
Kadowaki, S ;
Hagiwara, Y ;
Matsuo, K ;
Asanuma, H ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2559-2564
[5]   Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization [J].
Cho, JH ;
Lee, SW ;
Sung, YC .
VACCINE, 1999, 17 (9-10) :1136-1144
[6]   Influenza [J].
Cox, NJ ;
Subbarao, K .
LANCET, 1999, 354 (9186) :1277-1282
[7]   DNA based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice [J].
Davis, HL ;
Millan, CLB ;
Mancini, M ;
McCluskie, MJ ;
Hadchouel, M ;
Comanita, L ;
Tiollais, P ;
Whalen, RG ;
Michel, ML .
VACCINE, 1997, 15 (08) :849-852
[8]   Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine [J].
Deck, RR ;
DeWitt, CM ;
Donnelly, JJ ;
Liu, MA ;
Ulmer, JB .
VACCINE, 1997, 15 (01) :71-78
[9]   Effector CD4(+) and CD8(+) T-cell mechanisms in the control of respiratory virus infections [J].
Doherty, PC ;
Topham, DJ ;
Tripp, RA ;
Cardin, RD ;
Brooks, JW ;
Stevenson, PG .
IMMUNOLOGICAL REVIEWS, 1997, 159 :105-117
[10]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587